SCHEMBL2098547

SCHEMBL2098547

O=C(NCCO)C1c2ccccc2C(=O)N(Cc2ccc(Cl)cc2)C1c1ccc(Cl)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 5/20 0.79
TP53 P04637 2/20 0.79
ALDH1A1 P00352 3/20 0.52
MAPT P10636 2/20 0.52
HTT P42858 2/20 0.52
KDM4E B2RXH2 1/20 0.52
TSHR P16473 2/20 0.49
NPSR1 Q6W5P4 4/20 0.47
GAA P10253 2/20 0.47
BRS3 P32247 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
KCNA5 P22460 4/20 0.45
MEN1 O00255 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
RECQL P46063 1/20 0.44
KMT2A Q03164 1/20 0.44
KCNH2 Q12809 1/20 0.43
FFAR1 O14842 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29921543 1.00 MDM2 (0.79) MDM2TP53ALDH1A1MAPTHTT
SCHEMBL2054559 0.88 MDM2 (1.00) MDM2TP53ALDH1A1MAPTHTT
SCHEMBL2098874 0.88 MDM2 (1.00) MDM2TP53ALDH1A1MAPTHTT
SCHEMBL2054562 0.88 MDM2 (1.00) MDM2TP53ALDH1A1MAPTHTT
SCHEMBL2054560 0.88 MDM2 (1.00) MDM2TP53ALDH1A1MAPTHTT
SCHEMBL29921819 0.88 MDM2 (1.00) MDM2TP53ALDH1A1MAPTHTT
SCHEMBL2054563 0.88 MDM2 (1.00) MDM2TP53ALDH1A1MAPTHTT
SCHEMBL13179470 0.84 MDM2 (0.62) MDM2TP53ALDH1A1MAPTHTT
SCHEMBL2054558 0.83 MDM2 (1.00) MDM2TP53ALDH1A1MAPTHTT
SCHEMBL2054561 0.83 MDM2 (1.00) MDM2TP53ALDH1A1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163744-B2 Tetrahydro-isoquinolin-1-ones for the treatment of cancer NEXUSPHARMA, INC. (US) 2012-04-24 US claimed
US-8163744-B2 Tetrahydro-isoquinolin-1-ones for the treatment of cancer NEXUSPHARMA, INC. (US) 2012-04-24 US disclosed